Posters and Talks

Effect of multiple doses of ALX-009, A novel combination of hypothiocyanite and lactoferrin on microbial load in Cystic Fibrosis (CF)
J. Payne, R. Ingram, S. Elborn, D. Gilpin, V. Juarez-Perez, M. Tunney.
ECFS Sevilla, Spain, 40th annual congress, June 7-10, 2017


Poster 191

Activity of ALX-009, A novel combination of Hypothiocyanite and Lactoferrin against clinical Cystic Fibrosis (CF) respiratory pathogens.
J. Payne, R. Ingram, SJ. Elborn, D. Gilpin, V. Juarez-Perez, M. Tunney
NACFC Orlando, Florida, 30th annual congress, Oct 27-29, 2016

PDF icon

ALX-009 (OSCN-/bLF) efficacy against emergent Cystic Fibrosis pathogens
C. Bechetoille, L. Jubeau, V. Juarez-Perez
NACFC Orlando, Florida, 30th annual congress, Oct 27-29, 2016

PDF icon

Therapeutic Potential of Inhaled ALX-009 (OSCN-/ bLF) for the treatment of Achromobacter spp. infections in Cystic Fibrosis
C. Bechetoille, Y. Sonmez, L. Jubeau and V. Juarez-Perez
ECFS Basel, Switzerland , 39th annual congress , June 8-11, 2016

PDF icon

Therapeutic potential of inhaled ALX-009 (OSCN-/bLF) for emergent and multiresistant bacteria infections in Cystic Fibrosis,
Y. Sonmez, C. Bechetoille, S. Perrotto and V. Juarez-Perez
NACFC Phoenix, Arizona , 29th annual congress , Oct 8-10, 2015

PDF icon

Successful Burkholderia spp. eradication with hypothiocyanite/lactoferrin. In vitro study evidence over a worldwide collection of clinical strains,
Y. Sonmez, C. Bechetoille, S. Perrotto, A. Payet-Burin, V. Juarez-Perez
ECFS Brussels, Belgium, 38th annual congress , June 10-13, 2015

PDF icon

Burkholderia spp. Resistances strategies. OSCN-/bLF (ALX-009), Is its mode of action a bulwark against bacterial resistance?
Victor Juarez-Perez, Camille Bechetoille, Yasmine Somnez and Sandrine Perrotto
IBCWP Vancouver, Canada. 19th annual congress. April 15-18, 2015.

PDF icon

Bactericidal potential of OSCN-, bovine lactoferrin and their combination on clinical isolates of Burkholderia spp.
Y. Sonmez, C. Bechetoille, S. Perrotto, A. Payet-Burin, V. Juarez-Perez
NACFC Atlanta, Georgia, 28th annual congress , Oct 9-11, 2014

PDF icon

Bactericidal potential of OSCN-, bovine Lactoferrin and their combination over clinical strains of Burkholderia spp.
Y. Sonmez, C. Bechetoille, S. Perrotto, A. Payet-Burin, V. Juarez-Perez
IBCWP Nimes, France, 18th annual congress. April 8-12, 2014.

Feasibility study of OSCN− and lactoferrin (Meveol®) nebulization for Cystic Fibrosis patients

ALX-109 potentiates the effect of inhaled antibiotics at killing Pseudomonas aeruginosa biofilms on human airway cells,
S. Moreau-Marquis, J.D. Drexinger, V. Juarez Perez, B.A. Stanton
NACFC Orlando, Florida, 26th annual congress , Oct 11-13, 2012
ECFS Lisbon, Portugal, 36th annual congress , June 12-15, 2013

PDF icon

Feasibility study of OSCN- and lactoferrin (Meveol®) nebulization for Cystic Fibrosis patients,
S. Perrotto, S. Le Guellec, L. Vecellio, E. Fichant, P. Stordeur, P. Bordeau, J.P Perraudin
ECFS Hamburg, Germany, 34th annual congress , June 8-11, 2011

PDF icon

Laisser un commentaire

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Vous pouvez utiliser ces balises et attributs HTML : <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>